InsiderPulse
← 10-K / 10-Q
10-QBFNH

BIOFORCE NANOSCIENCES HOLDINGS, INC.

Filed 2026-05-19Period ending 2026-03-31
EDGAR ↗All periods →

Income Statement

Line Item2026-03-31Q/QY/Y
SG&A Expense$12K-56.8%
Pre-tax Income-$118K+11.8%
Net Income-$102K+89.0%
EPS (Basic)$0.00+100.0%
EPS (Diluted)$0.00+100.0%

Balance Sheet

Line Item2026-03-31Q/QY/Y
Cash & Equivalents$6K+707.5%-54.0%
Current Assets$6K+707.5%-54.0%
Total Assets$6K+707.5%-54.0%
Current Liabilities$727K+17.4%+164.4%
Total Liabilities$727K+17.4%+164.4%
Stockholders' Equity-$721K-16.6%-176.0%

Cash Flow

Line Item2026-03-31Q/QY/Y
Operating Cash Flow$7K+146.6%
Financing Cash Flow-$2K-105.4%